Corrigendum: Phase I trial outcome of amnion cell therapy in patients with ischemic stroke (I-ACT) (Frontiers in Neuroscience, (2023), 17, (1153231), 10.3389/fnins.2023.1153231)

Phan, TG; Lim, R; Krause, M; Chan, ST; McDonald, H; Gan, PY; Zhang, SR; Barreto Arce, LJ; Vuong, J; Thirugnanachandran, T; Clissold, Ben; Ly, J; Singhal, S; Hervet, MV; Kim, HA; Drummond, GR; Wallace, EM; Ma, H; Sobey, CG

Corrigendum: Phase I trial outcome of amnion cell therapy in patients with ischemic stroke (I-ACT) (Frontiers in Neuroscience, (2023), 17, (1153231), 10.3389/fnins.2023.1153231)

journal contribution

posted on 2023-10-20, 02:38 authored by TG Phan, R Lim, M Krause, ST Chan, H McDonald, PY Gan, SR Zhang, LJ Barreto Arce, J Vuong, T Thirugnanachandran, Ben ClissoldBen Clissold, J Ly, S Singhal, MV Hervet, HA Kim, GR Drummond, EM Wallace, H Ma, CG Sobey

Corrigendum: Phase I trial outcome of amnion cell therapy in patients with ischemic stroke (I-ACT) (Frontiers in Neuroscience, (2023), 17, (1153231), 10.3389/fnins.2023.1153231)

History

Journal

Frontiers in Neuroscience

Volume

17

Pagination

1-2

Location

Lausanne, Switzerland

Publisher DOI

https://doi.org/10.3389/fnins.2023.1237920

ISSN

1662-453X

eISSN

1662-453X

Language

eng

Author URL

https://www.ncbi.nlm.nih.gov/pubmed/37600008

Publication classification

C4.1 Letter or note

Publisher

Frontiers Media

Publication URL

http://dx.doi.org/10.3389/fnins.2023.1237920

Usage metrics

Keywords

allogeneic clinical trial ischemic stroke phase I stem cell

Licence

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

Corrigendum: Phase I trial outcome of amnion cell therapy in patients with ischemic stroke (I-ACT) (Frontiers in Neuroscience, (2023), 17, (1153231), 10.3389/fnins.2023.1153231)

History

Journal

Volume

Pagination

Location

Publisher DOI

ISSN

eISSN

Language

Author URL

Publication classification

Publisher

Publication URL

Usage metrics

Categories

Keywords

Licence

Exports